Alibaba
BABA
Netflix
NFLX
Broadcom
AVGO
4
Tesla
TSLA
5
Salesforce
CRM
US Stock MarketDetailed Quotes
BTAI BioXcel Therapeutics
- 2.666
- -0.304-10.23%
Trading Mar 11 10:25 ET
9.05MMarket Cap-0.08P/E (TTM)
3.140High2.620Low483.78KVolume3.070Open2.970Pre Close1.38MTurnover18.81%Turnover RatioLossP/E (Static)3.39MShares49.58452wk High-0.11P/B6.86MFloat Cap1.72052wk Low--Dividend TTM2.57MShs Float1144.000Historical High--Div YieldTTM17.51%Amplitude1.720Historical Low2.844Avg Price1Lot Size
BioXcel Therapeutics Key Stats
EPS
According to the latest financial report of BioXcel Therapeutics, the latest earnings per share (TTM) for the company is -5.12. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about BioXcel Therapeutics's free cash flow? The latest report shows it as -16.34M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of BioXcel Therapeutics shows that the company's current ratio is 1.87, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of BioXcel Therapeutics, the quick ratio is 1.58, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of BioXcel Therapeutics? The latest ROE figure is -181.81%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of BioXcel Therapeutics, the total asset return on investment (ROA) is -23.88%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check BioXcel Therapeutics's latest financial report to see how their gross margin is doing - currently at -446.73%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of BioXcel Therapeutics, the net profit margin is -6.38K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call